146 related articles for article (PubMed ID: 3909340)
1. Clinical evaluation of aztreonam therapy for serious infections due to gram-negative bacteria.
McKellar PP
Rev Infect Dis; 1985; 7 Suppl 4():S803-9. PubMed ID: 3909340
[TBL] [Abstract][Full Text] [Related]
2. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli.
Simons WJ; Lee TJ
Rev Infect Dis; 1985; 7 Suppl 4():S783-8. PubMed ID: 2934786
[TBL] [Abstract][Full Text] [Related]
3. Aztreonam therapy for serious gram-negative bacillary infections.
Cone LA; Woodard DR
Rev Infect Dis; 1985; 7 Suppl 4():S794-802. PubMed ID: 3909339
[TBL] [Abstract][Full Text] [Related]
4. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
Scully BE; Neu HC
Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
[TBL] [Abstract][Full Text] [Related]
5. The use of aztreonam in serious gram-negative infections.
Smith G; Bunney RG; Farrell ID; Wood MJ
J Antimicrob Chemother; 1988 Feb; 21(2):233-41. PubMed ID: 3283094
[TBL] [Abstract][Full Text] [Related]
6. Treatment of serious gram-negative infections with aztreonam.
Greenberg RN; Reilly PM; Luppen KL; McMillian R; Bollinger M; Wolk SM; Darji TB; Noorani AA
J Infect Dis; 1984 Nov; 150(5):623-30. PubMed ID: 6541672
[TBL] [Abstract][Full Text] [Related]
7. Current state of infectious diseases--potential areas of directed therapy with aztreonam.
Neu HC
Am J Med; 1985 Feb; 78(2A):77-80. PubMed ID: 4038580
[TBL] [Abstract][Full Text] [Related]
8. Aztreonam therapy for serious gram-negative infections in children.
Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
[TBL] [Abstract][Full Text] [Related]
9. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
12. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections.
Henry SA; Bendush CB
Am J Med; 1985 Feb; 78(2A):57-64. PubMed ID: 3881950
[TBL] [Abstract][Full Text] [Related]
13. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
14. Aztreonam-flucloxacillin double beta-lactam treatment as empirical therapy of serious infections in very elderly patients.
Knockaert DC; Dejaeger E; Nestor L; Verbist L; Pelemans W
Age Ageing; 1991 Mar; 20(2):135-9. PubMed ID: 2053504
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with aztreonam for treatment of infections in children.
Stutman HR
Rev Infect Dis; 1991; 13 Suppl 7():S582-5. PubMed ID: 2068462
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low-dose aztreonam in the treatment of moderate to severe infections due to gram-negative bacilli.
Clergeot A; Steru D; Rosset MA; Carbon C
Rev Infect Dis; 1991; 13 Suppl 7():S648-51. PubMed ID: 2068476
[TBL] [Abstract][Full Text] [Related]
17. Treatment of gram-negative infections with aztreonam.
Simons WJ; Lee TJ
Am J Med; 1985 Feb; 78(2A):27-30. PubMed ID: 4038577
[TBL] [Abstract][Full Text] [Related]
18. Aztreonam in the treatment of serious orthopedic infections.
Pribyl C; Salzer R; Beskin J; Haddad RJ; Pollock B; Beville R; Holmes B; Mogabgab WJ
Am J Med; 1985 Feb; 78(2A):51-6. PubMed ID: 3881949
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on aztreonam following intravenous drip infusion].
Yoshimoto M; Nakanishi Y; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Shimizu K; Ueda N
Jpn J Antibiot; 1985 Oct; 38(10):2827-37. PubMed ID: 4078996
[TBL] [Abstract][Full Text] [Related]
20. Successful response of severe neonatal gram-negative infection to treatment with aztreonam.
Constantopoulos A; Thomaidou L; Loupa H; Papoulias G
Chemotherapy; 1989; 35 Suppl 1():101-5. PubMed ID: 2731446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
